drugset

drugset / Trial / NCT00137735

Gabapentin for Carpal Tunnel Syndrome

NCT00137735 ↗

Phase 3 Completed 150 enrolled Chinese University of Hong Kong Pfizer · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether gabapentin is safe and effective in the treatment of carpal tunnel syndrome (CTS).

Timeline

Start: 2003-10
Primary completion: —
Completion: 2006-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Gabapentin	Small molecule	300 mg	—

Indications